Insight Molecular Diagnostics Inc. (IMDX) Operating cash flow 2016–2025
Insight Molecular Diagnostics Inc. (IMDX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$22.2MFY2025 · since FY2016: -$7.5M → -$22.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.2M | -7.2% |
| FY2024 | -$20.7M | +11.3% |
| FY2023 | -$23.3M | +48.8% |
| FY2022 | -$45.6M | -26.8% |
| FY2021 | -$35.9M | -38.3% |
| FY2020 | -$26.0M | -31.8% |
| FY2019 | -$19.7M | -69.2% |
| FY2018 | -$11.6M | +13.0% |
| FY2017 | -$13.4M | -77.9% |
| FY2016 | -$7.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice